CSNK1A1 and colorectal carcinoma: Similarly, in this work, we observed that BAMLET down-regulates the AKT/phospho-β-catenin (S552) axis and enhances the ability of CK1a inhibitor to decrease the expression of the AKT/phospho-β-catenin (S552) signaling in CRC cells harboring RAS mutation.